Investigators addressed challenges associated with the biology, diagnosis, and current state of treatment for patients with
Investigators summarize current literature surrounding the treatment of NLPHL and discuss treatment considerations for 2 clinical cases.
Healthcare providers should take steps now to ensure that the telehealth modalities they use are HIPAA compliant.
A pair of researchers discuss the treatment and specific clinical challenges associated with thrombotic thrombocytopenic purpura in women who are pregnant.
In addition to age, sex, and comorbidities, a new study flagged uncontrolled cancer and renal insufficiency as key prognostic factors for COVID-19 outcomes.
Investigators summarized current literature surrounding the diagnosis and risk-stratification of PV and ET, and reviewed available and upcoming therapies.
Depending on the type and stage of lymphoma, physicians may choose to avoid having their patients undergo radiation therapy for fear of potential toxic effects in organs.
The American Society of Hematology released evidence-based guidelines for the treatment of DVT and PE in patients without cancer.
Small studies, the absence of subtypes, and a historical lack of genetic information has stopped past studies from triggering meaningful public health change, a review asserts.
The British Society of Hematology has updated their guidelines on the use of irradiated blood components.
The British Society for Haematology has published updated guidelines for the diagnosis and management of chronic myeloid leukemia in adults and children.
Although 1 in 1000 lymphoma diagnoses occurs in pregnancy, literature on best practices for treatment in this patient group is limited.
An analysis showed that outcomes of SARS-CoV-2 infections can be disproportionately mild in some patient cohorts.
TTP is a rare disease that clinicians may not often treat; however, it is important to be aware of new developments for the treatment of this patient population.
The signaling pathways detected may shed light on new treatment strategies.
Recent guidelines have provided additional information on the treatment, management, and risk-stratifications of acute myeloid leukemia in older patients.
When talking about work issues, Dr Bernstein recommends trying not to focus too much on how awful things are because it can be disheartening.
An overview of the diagnosis and management of MDS, including recent treatment, was discussed in a paper published in the American Journal of Hematology.
Most patients achieved deep remission after a 14-month regimen of obinutuzumab, ibrutinib, and venetoclax.
How to explain adjustments to cancer care due to the COVID-19 pandemic and ease patients’ fears about the impact of those changes.
Researchers reviewed the clinical/pathologic aspects of HSTCL and summarized the latest molecular studies and potential novel therapeutic targets.
Practices need to know all of the components of their health information systems to determine potential vulnerabilities.
Engineered cytokine evades the tumor’s defenses and boosts the production of stem-like polyfunctional T cells.
FDA approves allogenic CAR T cells targeted at BCMA for phase 1 trial in relapsed/refractory multiple myeloma.
Researchers reviewed promising advances in therapy options for patients with CLL and the challenges associated with these new treatments.
Novel immunotherapies and small molecule pathway inhibitors are transforming the standard of care for some of the most challenging lymphoma subtypes.
Recent studies have better elucidated the link between clonal hematopoiesis and hematologic malignancies.
By connecting on a personal level, medical practices may have better results in getting patients to settle their accounts.
While the rate of certain HIV-linked non-Hodgkin lymphomas has declined since the introduction of ART, the incidence of Burkitt lymphoma has remained steady.
The social media platform can be useful as an education tool for oncologists to stay up to date on new research in oncology — but physicians still need to be mindful of the information sources.
The treatment reduced hospital stay but not neutropenia duration or infection rate.
As PKD directly affects the catalysis of substrates and products involved in the production of ATP, the glycolytic pathway is compromised, thus leading to several cellular defects.
Immunotherapy is changing the treatment paradigm for pediatric patients with relapsed acute lymphoblastic leukemia.
Hackers have penetrated healthcare providers’ computer systems to encrypt information and demand money for its release.
It remains important to interrogate how structural discrimination influences the collection of patient-reported outcomes.
Antoine N. Saliba, MD, and colleagues summarized current literature surrounding the frequent complications that bring patients with thalassemia into the ED.
Oncopeptides will seek accelerated approval from the FDA after melflufen demonstrates a manageable safety profile.
Beginning January 1, 2021, a federal law called the Every Prescription Conveyed Securely Act takes effect requiring that prescriptions for controlled substances covered under Medicare be prescribed electronically.
The American Society of Hematology released their evidence-based 2020 guidelines on the management of acute and chronic pain in sickle cell disease.
Communication breakdowns associated with a loss of hearing can potentially impact older patients’ adherence to treatment plans.
Researchers examine how far follicular lymphoma treatment has come, what limitations still remain, and where the management of the disease is headed.
Putting information in the cloud can be a good move for a physician’s practice — but only if done well.
COVID-19 has brought unprecedented stress to society at large and perhaps most of all to frontline healthcare teams in a variety of settings. We spoke to an expert about teamwork during such trying times.
In addition to being common yet serious diseases, both cancer and fibromyalgia bring a high burden of physical pain and negative effects on mental health.
Because primary pancreatic lymphoma is a rare disease, optimal diagnostic and therapeutic protocols have not yet been established.
Two recent papers are encouraging cancer center executives to rethink how they position their services to potential patients.
The British Society of Haematology released updates to 2 previous guidelines to help clinical laboratories with assays for coagulant diagnostic services.
There are up to 80 ADCs in clinical development with close to 600 ongoing trials.
The association between functional impairment and symptom burden was shown to be predictive of outcomes for older patients with advanced cancer.
Physicians should frame treatment options by their “harms and benefits,” not by their “risks and benefits.”